Introduction {#sec1-1}
============

*Terminalia chebula* Retz is a kind of large tree distributed throughout the world. The fruits and barks of *Terminalia chebula* Retz had been used as an ethnodrug from ancient times. In Myanmar, medicinal terminalia fruit is used as a laxative and a tonic. In China, it is applied as a carminative, astringent and texpectorant, and also as a remedy for excessive salivation and heartburn. In Indo-China, it is regarded as a purgative agent. In Malaysia, medicinal terminalia fruit is believed to exhibit anti-diarrheic, styptic, anti-bilious and anti-dysenteric activities.\[[@ref1]\] Previous studies revealed that *Terminalia chebula* Retz extract showed anti-bacterial,\[[@ref2][@ref3]\] anti-proliferative\[[@ref4]\] and anti-diabetic activities.\[[@ref5]\] Chebulagic acid isolated from the fruits was identified as a COX-2 and LOX-5 dual inhibitor and showed anti-proliferative and pro-apoptotic activities in several tumor cell lines.\[[@ref6]\] Recently, *Terminalia chebula* Retz extract was reported to possess against blood-sucking parasites\[[@ref7]\] and cytochrome P450 inhibition effect.\[[@ref8]\] Our previous study found that arjunic acid, a triterpene isolated from *Terminalia chebula* Retz is a potent-free radical scavenger.\[[@ref9]\] Triethylchebulate (TCL) is an aglycone isolated from *Terminalia chebula* Retz \[[Figure 1](#F1){ref-type="fig"}\].\[[@ref10]\] However, little is known about its bioactivity and pharmacological effects. In this study, its antioxidant capacity was evaluated extensively *in vitro*.

![Chemical structure of triethylchebulate](IJPharm-43-320-g001){#F1}

Materials and Methods {#sec1-2}
=====================

 {#sec2-1}

### Reagents and Animals {#sec3-1}

TCL (\>95%) was isolated and identified according to our previous report.\[[@ref11]\] Dry fruit of *Terminalia chebula* Retz (9 kg) was extracted with 95% ethanol, petroleum ether, ethyl acetate and 5% NaHCO~3~ sequentially, each for three times. The obtained extract (150 g) was isolated with a silica gel column chromatograph using chloroform/methanol gradient. TCL (900 mg) was collected at the gradient (50: l). Cysteine, trichloroacetic acid (TCA), thiobarbituric acid (TBA), butylated hydroxytoluene (BHT), ascorbic acid, 1,1-diphenyl-2-picrylhydrazyl (DPPH), ferrous sulfate (FeSO~4~), 2´,7´-dichlorodihydro-fluorescindiacetate (DCFH~2~-DA) were purchased from Sigma (USA).

The male Wistar rats (200--250 g) were purchased from Experimental Animal Center of Chinese Academy of Medical Sciences. All studies were approved by the Laboratories Institutional Animal Care and Use Committee of Chinese Academy of Medical Sciences and Peking Union Medical College.

### Preparation of Microsomes, Red Blood Cells and Mitochondria {#sec3-2}

Rats were starved overnight before experiment and the liver microsomes were isolated as previously reported.\[[@ref12]\] Protein content was determined by Lowry assay.\[[@ref13]\]

Red blood cells (RBCs) were isolated from blood by centrifugation and gently suspended with PBS-glucose (10 mM) to obtain proper percentage hematocrit.\[[@ref14]\]

Liver mitochondria were isolated as previous described and resuspended in determination medium.\[[@ref15]\] The protein content was determined by Lowry assay.\[[@ref13]\]

### Effect on Lipid Peroxidation {#sec3-3}

The effect of TCL on lipid peroxidation was performed by the measurement of TBARS.\[[@ref16]\] In brief, microsomes were incubated at 37°C in 0.1 M PBS, pH 7.5, and made up to a final protein concentration of 0.5 mg/ml. The peroxidation was initiated by 0.01 M cysteine and 1 mM ferrous sulfate (FeSO~4~) (final concentration) in a total volume of 1.0 ml. The reaction mixture was gently shaken at 37°C for 30 min, followed by addition of a TCA-TBA-HCl stock solution (15% w/v trichloroacetic acid; 0.375% w/v TBA; 0.25 N HCl) together with 0.02% w/v BHT. This amount of BHT completely prevents the formation of any non-specific TBARS.\[[@ref17]\] The solution was heated in a boiling water bath for 15 min. After centrifugation, the TBARS in the supernatant was determined at 532 nm\[[@ref18]\] with SPECTRA-max M5 (Molecular Devices, USA). Ascorbic acid was used as a reference compound.

### Effect on H~2~O~2~-induced RBCs Hemolysis {#sec3-4}

Freshly prepared RBCs were gently resuspended with PBS-glucose to obtain a 5% hematocrit, and pre-incubated at 37°C for 10 min in the presence of 1 mM sodium azide (to inhibit catalase activity). Subsequently, they were divided into various aliquots of 1 ml for each experimental treatment. All of these, except the control tubes, were challenged with 10 mM H~2~O~2~ with or without the addition of different concentrations of TCL. After 60 min at 37°C, cells were kept for 60 s in an ice bath and then centrifuged at 1800 g for 10 min at 4°C. About 200 *μ*l of the supernatant was taken to a 96-well plate and the absorbance was read at 514 nm\[[@ref19]\] with SPECTRA-max M5 (Molecular Devices, USA). Ascorbic acid was used as reference compound.

### Effect on RBCs Autoxidative Hemolysis {#sec3-5}

One milliliter of 1% hematocrit RBCs was taken to a test tube and different concentrations of TCL were added. The mixture was incubated in a water bath at 37°C. The test tubes were oscillated gently every 2 h, and after 24 h of incubation the test tubes were then centrifuged at 1800 g for 10 min. Two hundred microliters of the supernatant was taken to a 96-well plate and the absorbance was read at 540 nm\[[@ref20]\] SPECTRA-max M5 (Molecular Devices, USA). Ascorbic acid was used as reference compound.

### DPPH Free Radical Scavenging Activity {#sec3-6}

The DPPH radical-scavenging effect was measured according to the method of Kang and Saltveit.\[[@ref21]\] Different concentrations of TCL (10 *μ*l) were mixed with 190 *μ*l DPPH radical (1 *μ*M) in a methanol solution. After 20-min incubation at room temperature in the dark, the absorbance was read at 517 nm\[[@ref22]\] with SPECTRA-max M5 (Molecular Devices, USA). Ascorbic acid was used as reference compound.

### Effect on Sodium Azide Induced Mitochondrial ROS Production {#sec3-7}

The DCFH~2~-DA assay was performed in a volume of 200 *μ*l reaction system in black 96-well plates containing determination medium (final concentration) (NaCl 153 mM, KCl 2.68 mM, MgCl~2~ 1.0 mM, Tris-HCl 10 mM, glucose 20 mM, pH 7.4), 0.3 mg/ml (mitochondrial protein), 1 mM sodium succinate, 2 *μ*M DCFH~2~-DA and 0.1 mM sodium azide. TCL was added to the mitochondria solution before the addition of sodium azide to minimize DCFH~2~-DA oxidation by the radicals produced with sodium azide and the sodium succinate was added at last to initiate mitochondria respiration.\[[@ref23]\] After a few seconds of oscillation, the plates were kept at 37°C for 30 min in the dark and the fluorescence was determined at 492 nm/520 nm\[[@ref24]\] with SPECTRA-max M5 (Molecular Devices, USA). Ascorbic acid was used as reference compound.

### Statistical Analysis {#sec3-8}

Data are expressed as mean ± SD. The significance of intergroup differences was evaluated by one-way analyses of variance (one-way-ANOVA) using software SPSS11.5. Differences were considered significant at *P* \< 0.05.

Results {#sec1-3}
=======

In the FeSO~4~/Cys-induced microsomes lipid peroxidation model, TCL has a strong inhibitory effect on FeSO~4~/Cys-induced MDA formation as determined by TBARS assay. Furthermore, a dose-dependent inhibitory effect was observed. Compared with the same concentration of ascorbic acid, TCL showed a much higher inhibitory effect \[[Figure 2](#F2){ref-type="fig"}\].

![Inhibitory effect of TCL on rat liver microsomal MDA formation (∗∗*P*\<0.01 versus ascorbic acid, ∗*P*\<0.05 versus ascorbic acid). Vit. C, ascorbic acid](IJPharm-43-320-g002){#F2}

TCL significantly decreased H~2~O~2~-induced RBCs hemolysis in a dose-dependent manner and even at as low as 5×10^-6^ M it showed clear inhibitory effect (25.5%±4.6%). The calculated IC~50~ was 4.2×10^-5^ M. Compared with the same concentration of ascorbic acid, TCL showed a much higher inhibition \[[Figure 3](#F3){ref-type="fig"}\]. Similar inhibitory effect on RBCs autoxidative hemolysis was also observed but with much lower inhibitory rate \[[Figure 4](#F4){ref-type="fig"}\].

![Inhibitory effect of TCL on H~2~O~2~-induced RBCs hemolysis (∗∗*P*\<0.01 versus ascorbic acid, ∗*P*\<0.05 versus ascorbic acid). Vit. C, ascorbic acid](IJPharm-43-320-g003){#F3}

![Inhibitory effect of TCL on RBCs autoxidative hemolysis (∗∗*P*\<0.01 versus ascorbic acid, ∗*P*\<0.05 versus ascorbic acid). Vit. C, ascorbic acid](IJPharm-43-320-g004){#F4}

DPPH test showed that TCL is a strong DPPH free-radical scavenger and even at 1.5×10^-6^ M, it showed inhibitory effect (13.3%±6.7%, *P*\<0.05 vs. control). An obvious dose-dependent manner was observed with calculated IC~50~=2.4×10^-5^ M. Ascorbic acid showed similar potency \[[Figure 5](#F5){ref-type="fig"}\].

![Effect of TCL on DPPH free radical (∗*P*\>0.05 versus ascorbic acid) Vit. C, ascorbic acid](IJPharm-43-320-g005){#F5}

Sodium azide induced mitochondrial ROS production was suppressed to some degree. The inhibitory rate at 1×10^-4^ M was only about 26.4%. Ascorbic acid at this concentration showed much higher ROS scavenge ability \[[Figure 6](#F6){ref-type="fig"}\].

![TCL-inhibited sodium azide induced mitochondrial ROS production. Results are expressed as inhibitory rate of DCF formation. (∗∗*P*\<0.05 versus ascorbic acid, ∗*P*\<0.05 versus ascorbic acid). Vit. C, ascorbic acid](IJPharm-43-320-g006){#F6}

Discussion {#sec1-4}
==========

In recent years, the antioxidant ability of *Terminalia chebula* Retz has been reported. An aqueous extract significantly reversed t-BHP-induced hepatocyte cytotoxicity *in vitro* and liver oxidative stress injury *in vivo*.\[[@ref25]\] Several pure compounds such as casuarinin, chebulanin, chebulinic acid, 1,6-di-*O*-galloyl-b-D-glucose and chebulic acid also showed anti-lipid peroxidation, anti-superoxide radical formation and free-radical scavenging activities.\[[@ref1][@ref26]\] However, there are few reports about the biological effect of TCL. To the best of our knowledge, this is the first study reporting the antioxidant activities of TCL.

MDA, one of the products of lipid peroxidation, is widely used for determination of lipid peroxidation.\[[@ref18]\] TCL dose dependently inhibited FeSO~4~/Cys-induced microsomes MDA formation suggesting that TCL might act as a free-radical scavenger. RBC was an excellent model for membrane studies and redox analysis. Significant inhibition of H~2~O~2~-induced RBC hemolysis and autoxidative hemolysis revealed that TCL could protect membrane destruction from oxidative injury. The *μ*M level of IC~50~ and a much higher inhibitory rate than that of ascorbic acid make it a potential agent for further study. It is interesting to note that TCL showed higher potency in H~2~O~2~-induced hemolysis than in autoxidative hemolysis. DCFH~2~-DA is an oxidative stress sensitive fluorescent dye widely used for ROS measurements both in cells and mitochondria.\[[@ref27]\] Mitochondrion is both the energy houses and the most important sources of ROS in cells. Inhibition of mitochondrial ROS formation might provide protection for mitochondria from oxidative injury. DPPH reactivity is a popular method for screening the free-radical scavenging ability of compounds or the anti-oxidant activity of plant extracts. Some compounds were active in the DPPH assay but significantly less active in the DCFH system.\[[@ref28]\] However, TCL was active in both the DPPH and the DCFH assays.

In summary, our study revealed that TCL, a natural product from *Terminalia chebula* Retz. was a strong anti-oxidant and free-radical scavenger. The anti-oxidant and free-radical scavenging activity might be one of the mechanisms involved in *Terminalia chebula* Retz.\'s beneficial effect.
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